Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options
Abstract Background Patients newly diagnosed with lung adenocarcinoma with bone metastases (LABM) have poor survival rates after treatment with conventional therapies.To improve outcomes, we retrospectively investigated whether the application 7 Piece Counter Dining Set of a more comprehensive genetic test of tumor biopsies samples from LABM patien